<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26553" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pancoast Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Villgran</surname>
            <given-names>Vipin D.</given-names>
          </name>
          <aff>Allegheny General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chakraborty</surname>
            <given-names>Rebanta K.</given-names>
          </name>
          <aff>Steward Medical\Good Samaritan Medical</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cherian </surname>
            <given-names>Sujith V.</given-names>
          </name>
          <aff>UT Health-McGovern Medical School, Houston</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vipin Villgran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebanta Chakraborty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sujith Cherian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26553.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Superior pulmonary sulcus tumors, also called Pancoast tumors, arise from the apical pleuropulmonary groove located superior to the first rib. When these tumors involve the surrounding structures such as the brachial plexus, cervical paravertebral sympathetic nervous system, and stellate ganglion, they cause a group of signs and symptoms that are collectively called Pancoast syndrome. This is characterized by ipsilateral shoulder and arm pain, paresthesias, paresis and atrophy of the thenar muscles of the hand, and Horner's syndrome (ptosis, miosis, and anhidrosis). This activity reviews Pancoast syndrome and highlights the role of the interprofessional team in recognition and management of patients affected by this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the differential diagnosis of Pancoast syndrome.</p></list-item><list-item><p>Describe how to counsel a patient with Pancoast syndrome.</p></list-item><list-item><p>Explain the pathophysiology of Pancoast syndrome.</p></list-item><list-item><p>Summarizee the role of collaboration amongst interprofessional team members to improve care coordination and minimize oversight, leading to earlier diagnosis and treatment and better outcomes for patients with Pancoast syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26553&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26553">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26553.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Superior pulmonary sulcus tumors or Pancoast tumors arise from the apical pleuro-pulmonary groove superior to the first rib. When these tumors involve the surrounding structures such as the brachial plexus, cervical paravertebral sympathetic nervous system, and stellate ganglion, they cause a group of signs and symptoms collectively called Pancoast syndrome. This is characterized by the ipsilateral shoulder and arm pain, paresthesias, paresis, and atrophy of the thenar muscles of the hand, and Horners syndrome (ptosis, miosis, and anhidrosis). However, the Pancoast syndrome should be differentiated from the Pancoast tumor. The most common cause of the syndrome is primary bronchogenic carcinoma. The Pancoast syndrome is characterized by radiating parascapular pain, the hand's intrinsic muscles atrophy, and the presence of&#x000a0;a density at the apex of the lung with localized destruction of ribs and vertebrae.<xref ref-type="bibr" rid="article-26553.r1">[1]</xref><xref ref-type="bibr" rid="article-26553.r2">[2]</xref><xref ref-type="bibr" rid="article-26553.r3">[3]</xref><xref ref-type="bibr" rid="article-26553.r4">[4]</xref></p>
      </sec>
      <sec id="article-26553.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Tumors in the superior sulcus of the lung, typically non-small cell lung cancer, cause Pancoast syndrome. Among all lung cancers, non-small cell lung cancer (NSCLC) accounts for the majority with up to 80% to 85% of all cases, whereas Pancoast tumors by themselves account for roughly 3% to 5% of all lung cancers. More than 95% of Pancoast tumors are NSCLC, and among NSCLC, squamous cell carcinoma used to be the most common histologic type; however, lately, studies have been showing a predominance of adenocarcinoma.<xref ref-type="bibr" rid="article-26553.r5">[5]</xref></p>
        <p>Other than bronchogenic carcinomas, malignancies such as primary adenoid cystic carcinomas, thyroid carcinomas, lymphomas, or metastasis from any primary carcinoma or even benign tumors occupying the superior pulmonary sulcus are known to cause Pancoast syndrome. Rarely, other malignancies, including paravertebral thoracic schwannoma and myxofibrosarcoma, may cause the clinical findings pertinent with the Pancoast syndrome.<xref ref-type="bibr" rid="article-26553.r6">[6]</xref><xref ref-type="bibr" rid="article-26553.r7">[7]</xref> Even apical lung infections or abscesses can cause Pancoast syndrome involving the chest wall and surrounding structures.<xref ref-type="bibr" rid="article-26553.r8">[8]</xref><xref ref-type="bibr" rid="article-26553.r9">[9]</xref><xref ref-type="bibr" rid="article-26553.r10">[10]</xref></p>
      </sec>
      <sec id="article-26553.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Lung cancer is the second most common cancer and is the main cause of oncological mortality in either gender, both in the United States and globally. There were more than 200,000 cases of lung cancer in 2017 and with a 5-year survival rate of 18%, more than 150,000 died from lung cancer in 2017. Among all lung cancers, non-small cell lung cancer accounts for the majority with up to 80% to 85% of all cases; whereas, Pancoast tumors by themselves account for roughly 3% to 5% of all lung cancers.<xref ref-type="bibr" rid="article-26553.r11">[11]</xref></p>
      </sec>
      <sec id="article-26553.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Pancoast or superior sulcus tumors, when they compress or invade the surrounding structures, cause a group of symptoms collectively called Pancoast syndrome. They typically involve the brachial plexus first and cause shoulder and arm pain in almost all patients. They can also involve the parietal pleura, ribs, or vertebral bodies and cause pain. Since pulmonary symptoms occur late in these patients, initial symptoms are often misdiagnosed as musculoskeletal, and diagnosis is often delayed.<xref ref-type="bibr" rid="article-26553.r12">[12]</xref></p>
        <p>When the tumor extends further, it can also cause C8 through T1 radiculopathy with pain and paresthesia of the medial half of the fourth finger, fifth finger, and medial side of the hand, forearm, and arm. The weakness of intrinsic hand muscles affects fine motor skills and handgrip.<xref ref-type="bibr" rid="article-26553.r13">[13]</xref><xref ref-type="bibr" rid="article-26553.r14">[14]</xref><xref ref-type="bibr" rid="article-26553.r15">[15]</xref></p>
        <p>When the tumor involves the sympathetic trunk and the cervical ganglion, initially patients can develop ipsilateral facial flushing and sweat due to irritation. Later with invasion, Horner syndrome with ipsilateral ptosis, miosis, and anhidrosis can be seen along with sometimes contralateral flushing and sweating as well. This happens due to a hyperactive contralateral sympathetic reaction called Harlequin syndrome.<xref ref-type="bibr" rid="article-26553.r16">[16]</xref><xref ref-type="bibr" rid="article-26553.r17">[17]</xref></p>
      </sec>
      <sec id="article-26553.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Squamous cell carcinoma historically has been the most common subtype associated with Pancoast tumors. However, adenocarcinoma has been predominant in recent times. Overall, the overwhelming majority of Pancoast tumors are non-small cell lung cancer (NSCLC).<xref ref-type="bibr" rid="article-26553.r18">[18]</xref></p>
      </sec>
      <sec id="article-26553.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pancoast syndrome refers to the collective group of symptoms associated with these tumors, which is secondary to the involvement of brachial plexus and associated chest wall, vertebral, or rib pain. Shoulder or arm pain with associated paresthesias along the medial half of the fourth, fifth fingers and medial side of the hand, arm, and forearm due to C8 through T1 radiculopathy are usually primary symptoms associated. Since they are apically located, pulmonary symptoms of shortness of breath do not develop until later, as the tumor begins to involve more of the lung.<xref ref-type="bibr" rid="article-26553.r19">[19]</xref><xref ref-type="bibr" rid="article-26553.r14">[14]</xref><xref ref-type="bibr" rid="article-26553.r20">[20]</xref></p>
        <p>Physical examination findings include ipsilateral facial flushing and sweating due to the involvement of the sympathetic trunk and cervical ganglion. Horner syndrome with ptosis, miosis and anhidrosis may also develop with the further extent of the tumor.<xref ref-type="bibr" rid="article-26553.r8">[8]</xref></p>
      </sec>
      <sec id="article-26553.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are no laboratory abnormalities specific to the Pancoast tumor.&#x000a0;</p>
        <p>A chest x-ray can be used for initial screening, which shows the increased size of the apical cap or apical mass of the lung. CT scan provides additional information with regards to the extent of the tumor, satellite nodules, as well as mediastinal adenopathy, all of which are vital in the staging of these tumors. Although CT has poor sensitivity and specificity for accurate local staging, especially in evaluating the brachial plexus, subclavian vessel, and chest wall involvement, it identifies bony involvement.<xref ref-type="bibr" rid="article-26553.r9">[9]</xref><xref ref-type="bibr" rid="article-26553.r21">[21]</xref></p>
        <p>MRI of the neck, chest and upper abdomen usually is done after the diagnosis is made and before surgery to identify the extent of vascular and brachial plexus involvement. However, MRI has been suggested as more useful in these tumors, as it helps better delineate&#x000a0;soft tissue involvement, invasion of brachial plexus, vasculature, and spinal involvement. Therefore, MRI is currently preferred on potentially surgically resectable tumors.<xref ref-type="bibr" rid="article-26553.r6">[6]</xref></p>
        <p>Due to the outer location of these tumors, CT-guided core biopsy is the diagnostic test of choice with a reported yield of more than 90%. Bronchoscopy has been reported to be diagnostic in around 30% to 40% of the cases, which maybe&#x000a0;because of the&#x000a0;presence of an additional endobronchial tumor. Sputum cytology and scalene node biopsies usually have a low yield.<xref ref-type="bibr" rid="article-26553.r22">[22]</xref><xref ref-type="bibr" rid="article-26553.r23">[23]</xref></p>
      </sec>
      <sec id="article-26553.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The Standard of care is currently chemoradiation therapy followed by surgical resection.<xref ref-type="bibr" rid="article-26553.r1">[1]</xref><xref ref-type="bibr" rid="article-26553.r23">[23]</xref><xref ref-type="bibr" rid="article-26553.r24">[24]</xref><xref ref-type="bibr" rid="article-26553.r25">[25]</xref><xref ref-type="bibr" rid="article-26553.r26">[26]</xref></p>
        <p>Induction chemoradiation therapy involves chemotherapeutic regimens, including Cisplatin/Etoposide or Cisplatin/Mitomycin C/Vindesine. Radiation therapy regimes usually include 45 Gy/27 fractions over 5 to 6 weeks, followed by surgery in 4 to 6 weeks after completion of chemoradiation therapy.<xref ref-type="bibr" rid="article-26553.r27">[27]</xref><xref ref-type="bibr" rid="article-26553.r28">[28]</xref></p>
        <p>Contraindications to surgical resection include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Presence of metastases</p>
          </list-item>
          <list-item>
            <p>Involvement of ipsilateral or contralateral mediastinal nodes or supraclavicular nodes</p>
          </list-item>
          <list-item>
            <p>Involvement of vertebral bodies greater than 50%&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Involvement of esophagus and/ trachea</p>
          </list-item>
          <list-item>
            <p>Involvement of brachial plexus above T1 nerve root<xref ref-type="bibr" rid="article-26553.r29">[29]</xref><xref ref-type="bibr" rid="article-26553.r30">[30]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26553.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other malignancies either primary adenoid cystic carcinomas, hemangiopericytomas, thyroid carcinomas, lymphomas, plasmacytomas, or metastasis from any primary carcinoma, or even benign tumors occupying the superior pulmonary sulcus are known to cause Pancoast syndrome.<xref ref-type="bibr" rid="article-26553.r31">[31]</xref></p>
        <p>Even apical lung infections or abscesses can also cause Pancoast syndrome if they involve the chest wall and surrounding structures.<xref ref-type="bibr" rid="article-26553.r32">[32]</xref></p>
      </sec>
      <sec id="article-26553.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Resectable NSCLC superior sulcus tumors (T3 invasion, N0-1) are best treated with trimodality therapy comprising systemic chemotherapy, radiation treatments, and surgical resection. NCCN panel advocates for neoadjuvant concomitant chemotherapy and radiation treatments accompanied by surgical resection and chemotherapy again. This practice of neoadjuvant chemoradiation before surgery has shown a 2-year survival of approximately 50 to 70% and a 5-year survival rate of roughly 40%.<xref ref-type="bibr" rid="article-26553.r33">[33]</xref></p>
        <p>For T3&#x02013;4, N0&#x02013;1 lesions involving chest wall, proximal airway, or mediastinum, surgery is done first followed by chemotherapy alone if surgical margins are negative. If surgical margins are positive, they receive concurrent chemoradiation followed by re-resection and chemotherapy.<xref ref-type="bibr" rid="article-26553.r34">[34]</xref><xref ref-type="bibr" rid="article-26553.r11">[11]</xref></p>
      </sec>
      <sec id="article-26553.s12" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>In patients with unresectable NSCLC superior sulcus tumors (T4 extension, N0&#x02013;1) full dose systemic chemotherapy is given concurrently with radiation treatments. These tumors can be reassessed with CT or FDG-PET/CT scans after treatments for resectability. If the lesion remains unresectable, these patients may benefit from consolidation therapy with durvalumab which is an anti-PD-L1 monoclonal antibody (Programmed Death Ligand 1) after completion of chemoradiation.</p>
      </sec>
      <sec id="article-26553.s13" sec-type="Staging">
        <title>Staging</title>
        <p>Roughly three-quarters of Pancoast tumors are stage III tumors as they involve the parietal pleura, and the rest are regularly stage IIB and stage IV with the involvement of brachial plexus, mediastinum, great vessels, vertebral body, or with distant metastases.</p>
        <p>According to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, Eighth Edition, stage IIB now includes any tumor regardless of its size with metastasis or direct invasion of ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, i.e., all N1 tumors. Stage IIB also includes T3 tumors which are greater than 5 cm but less than or equal to 7 cm in greatest dimension or directly invading parietal pleura, chest wall, phrenic nerve, parietal pericardium, or with 1&#x000a0;or more separate tumor nodules in the same lobe as the primary.</p>
        <p>Stage III includes any tumor regardless of its size with N2 or N3 regional node involvement. These are tumors with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes (N2) and metastasis to contralateral mediastinal and/or hilar lymph nodes as well as scalene and/or supraclavicular lymph nodes regardless of laterality (N3). Stage III also includes T3 tumors with N1 lymph node involvement and any T4 tumor. T4 tumors are greater than 7 cm or invading the diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina or with&#x000a0;1&#x000a0;or more tumor nodules in an ipsilateral lobe that is different from that of the primary.<xref ref-type="bibr" rid="article-26553.r27">[27]</xref></p>
      </sec>
      <sec id="article-26553.s14" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>As with most other malignancies, patients with early-stage disease at diagnosis and better performance status have a good prognosis; whereas, advanced disease, poor performance status, and weight loss are indicators of poor outcomes. Also, metastatic NSCLC patients eligible for treatment with targeted therapies have a better prognosis compared with those without targetable genomic variations.</p>
        <p>It is very important to promptly identify the symptoms and diagnose Pancoast syndrome as they are usually stage IIB or higher by the time they are diagnosed. Early detection, staging,&#x000a0;and treatment are therefore critical for long-term survival.<xref ref-type="bibr" rid="article-26553.r35">[35]</xref></p>
      </sec>
      <sec id="article-26553.s15" sec-type="Complications">
        <title>Complications</title>
        <p>The complications are chiefly related to the treatments:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgery: Atelectasis, pain, chest wall deformity, frozen shoulder, CSF leak, prolonged air leak, injury to the brachial plexus</p>
          </list-item>
          <list-item>
            <p>Chemotherapy: Side effects from the drugs</p>
          </list-item>
          <list-item>
            <p>Radiation: alopecia, nausea, vomiting, leathery skin, poor wound healing</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26553.s16" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonologist</p>
          </list-item>
          <list-item>
            <p>Thoracic surgeon</p>
          </list-item>
          <list-item>
            <p>Pain specialist</p>
          </list-item>
          <list-item>
            <p>Critical care specialist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26553.s17" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>NSCLC is the most common cancer associated with Pancoast tumor.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pancoast syndrome refers to superior sulcus tumors along with ipsilateral shoulder and arm pain, paresthesias, paresis and atrophy of the thenar muscles of the hand and Horners syndrome (ptosis, miosis, and anhidrosis).&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Trans-thoracic needle biopsy usually achieves a diagnosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Preoperative evaluation will need MRI to delineate vascular involvement.</p>
          </list-item>
          <list-item>
            <p>Treatment involves chemoradiation therapy followed by surgical resection.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26553.s18" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pancoast tumor has no cure, and the survival is abysmal. The cancer is often diagnosed late, and patients are subject to complex surgery which is not only painful but rarely results in a cure. Thus, the emphasis today is on prevention. One of the most common causes of lung cancer is smoking and nurses and pharmacists are in a prime position to educate the patients about the adverse effects of tobacco. Plus the nurse can educate the patient on the type of surgery, the potential side effects of radiation therapy, and chemotherapy. The pharmacist can also recommend aids to stop smoking. Further, the pharmacist can educate the patient on work hazards that have been linked to lung cancer. Finally, the patient must be educated on a healthy lifestyle, exercise and abstaining from alcohol. This advice has benefits beyond lung cancer- it can improve the quality of life and lower the cost of healthcare.<xref ref-type="bibr" rid="article-26553.r36">[36]</xref><xref ref-type="bibr" rid="article-26553.r24">[24]</xref> (Level V)</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The prognosis for most patients with Pancoast&#x000a0;cancer is poor. Less than 30% are alive at five years. To date, radiation therapy has made no difference in locoregional recurrence or long-term survival. For those who undergo surgery, the quality of life is very poor, and the pain from the surgery can be debilitating.<xref ref-type="bibr" rid="article-26553.r37">[37]</xref><xref ref-type="bibr" rid="article-26553.r36">[36]</xref>&#x000a0;(Level III)</p>
      </sec>
      <sec id="article-26553.s19">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26553&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26553">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/pancoast-syndrome-superior-pulmonary-sulcus-tumors/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26553">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26553/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26553">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26553.s20">
        <title>References</title>
        <ref id="article-26553.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kratz</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Woodard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jablons</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Management of Lung Cancer Invading the Superior Sulcus.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2017</year>
            <month>May</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-157</page-range>
            <pub-id pub-id-type="pmid">28363369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Porpodis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Domvri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eleftheriadou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ioannidou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing and treating pancoast tumors.</article-title>
            <source>Expert Rev Respir Med</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>1255</fpage>
            <page-range>1255-1258</page-range>
            <pub-id pub-id-type="pmid">27786592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marulli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Battistella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mammana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calabrese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rea</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Superior sulcus tumors (Pancoast tumors).</article-title>
            <source>Ann Transl Med</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>12</issue>
            <fpage>239</fpage>
            <pub-id pub-id-type="pmid">27429965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Quintela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Quispe-Cornejo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Freitas-Silva</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pancoast Tumor as the Initial Presentation of a Metastatic Colon Adenocarcinoma.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Feb</month>
            <day>16</day>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>e13371</fpage>
            <pub-id pub-id-type="pmid">33747663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Rehmani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Borz-Baba</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pancoast-Tobias Syndrome: A Unique Presentation of Lung Cancer.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Feb</month>
            <day>03</day>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>e13112</fpage>
            <pub-id pub-id-type="pmid">33728131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alshammari</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Alotaibi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Alali</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Alkhileiwi</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Alshammari</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Albagami</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Alarimah</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Aldughaim</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Alsadady</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Alshammari</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Alhedires</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Albejais</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Alharbi</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Alharthi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Alshammari</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Schwannoma: A Rare Etiology of Pancoast Syndrome.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>13</volume>
            <issue>11</issue>
            <fpage>e19418</fpage>
            <pub-id pub-id-type="pmid">34909333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jevremovic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yousuf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Abboud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chedrawy</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>A rare presentation of myxofibrosarcoma as a Pancoast tumor: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2017</year>
            <month>Mar</month>
            <day>07</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <pub-id pub-id-type="pmid">28264709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panagopoulos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leivaditis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Koletsis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Prokakis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alexopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baltayiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hatzimichalis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kougioumtzi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Machairiotis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsiouda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kesisis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Siminelakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Madesis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dougenis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumors: characteristics and preoperative assessment.</article-title>
            <source>J Thorac Dis</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>6 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S108</fpage>
            <page-range>S108-15</page-range>
            <pub-id pub-id-type="pmid">24672686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foroulis</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Darwiche</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Machairiotis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karapantzos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment.</article-title>
            <source>J Thorac Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>5 Suppl 4</volume>
            <issue>Suppl 4</issue>
            <fpage>S342</fpage>
            <page-range>S342-58</page-range>
            <pub-id pub-id-type="pmid">24102007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Choudhury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Basuthakur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pancoast's Syndrome due to Fungal Abscess in the Apex of Lung in an Immunocompetent Individual: A Case Report and Review of the Literature.</article-title>
            <source>Case Rep Pulmonol</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>581876</fpage>
            <pub-id pub-id-type="pmid">25302130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Casiraghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brambilla</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maisonneuve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spaggiari</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Surgical Treatment of Superior Sulcus Tumors: A 15-Year Single-center Experience.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <string-date>2017 Spring</string-date>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-88</page-range>
            <pub-id pub-id-type="pmid">28684003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gundepalli</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Tadi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Lung Pancoast Tumor</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">32310569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Stefano</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Valdesi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pancoast's syndrome caused by lymph node metastasis from breast cancer.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Nov</month>
            <day>28</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30567112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugathas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rajwani</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Dev</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumour presenting as shoulder pain with Horner's syndrome.</article-title>
            <source>BMJ Case Rep</source>
            <year>2019</year>
            <month>Jan</month>
            <day>24</day>
            <volume>12</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30683661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kjellsen</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Faiz</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Rugland</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[A man in his sixties with pain, paresis and atrophy in his arm].</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2019</year>
            <month>Mar</month>
            <day>12</day>
            <volume>139</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30872839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khadilkar</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Khade</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Brachial plexopathy.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-8</page-range>
            <pub-id pub-id-type="pmid">23661957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumors.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>545</fpage>
            <page-range>545-57, v-vi</page-range>
            <pub-id pub-id-type="pmid">19010280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darling</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Viswanath</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ranjan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pathi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rathore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pathak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India.</article-title>
            <source>J Cancer Res Ther</source>
            <year>2020</year>
            <season>Jul-Sep</season>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>771</fpage>
            <page-range>771-779</page-range>
            <pub-id pub-id-type="pmid">32930117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Shammari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Jawad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Almansour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Yousif</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sebiany</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bin Bakr</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Pancoast Tumor: The Overlooked Etiology of Shoulder Pain in Smokers.</article-title>
            <source>Am J Case Rep</source>
            <year>2020</year>
            <month>Sep</month>
            <day>11</day>
            <volume>21</volume>
            <fpage>e926643</fpage>
            <pub-id pub-id-type="pmid">32913177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iss&#x00131;</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Erkin</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Do we inspecting the patient face who has shoulder pain?].</article-title>
            <source>Agri</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-112</page-range>
            <pub-id pub-id-type="pmid">32297960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manenti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Raguso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Onofrio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Altobelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scarano</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Vasili</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Simonetti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumor: the role of magnetic resonance imaging.</article-title>
            <source>Case Rep Radiol</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>479120</fpage>
            <pub-id pub-id-type="pmid">23607032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Meyers</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Larner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DR</given-names>
              </name>
              <collab>American College of Chest Physicians</collab>
            </person-group>
            <article-title>Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).</article-title>
            <source>Chest</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3 Suppl</issue>
            <fpage>290S</fpage>
            <page-range>290S-305S</page-range>
            <pub-id pub-id-type="pmid">17873175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Detterbeck</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kernstine</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Naunheim</surname>
                <given-names>KS</given-names>
              </name>
              <collab>American College of Physicians</collab>
            </person-group>
            <article-title>Lung cancer. Special treatment issues.</article-title>
            <source>Chest</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>123</volume>
            <issue>1 Suppl</issue>
            <fpage>244S</fpage>
            <page-range>244S-258S</page-range>
            <pub-id pub-id-type="pmid">12527583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kozower</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Larner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Detterbeck</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.</article-title>
            <source>Chest</source>
            <year>2013</year>
            <month>May</month>
            <volume>143</volume>
            <issue>5 Suppl</issue>
            <fpage>e369S</fpage>
            <page-range>e369S-e399S</page-range>
            <pub-id pub-id-type="pmid">23649447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tashi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kapisyzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Xhemalaj</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Andoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peposhi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumor approach through oesophagus.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2017</year>
            <volume>22</volume>
            <fpage>218</fpage>
            <page-range>218-219</page-range>
            <pub-id pub-id-type="pmid">28913160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piazza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Duranti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>The transmanubrial osteomuscular-sparing approach: a valuable adjunct to the head and neck surgical armamentarium.</article-title>
            <source>Curr Opin Otolaryngol Head Neck Surg</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-67</page-range>
            <pub-id pub-id-type="pmid">32011400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeannin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Merle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Janicot</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thibonnier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kwiatkowski</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Naame</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chadeyras</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Galvaing</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Belliere</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Filaire</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Verrelle</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.</article-title>
            <source>Chin Clin Oncol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">26730751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Atrchian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Humer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Siever</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical outcomes of pancoast tumors treated with trimodality therapy.</article-title>
            <source>J Thorac Dis</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>3529</fpage>
            <page-range>3529-3538</page-range>
            <pub-id pub-id-type="pmid">34277048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanner</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Silvestri</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes.</article-title>
            <source>Chest</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>148</volume>
            <issue>6</issue>
            <fpage>1373</fpage>
            <page-range>1373-1375</page-range>
            <pub-id pub-id-type="pmid">26110373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Burgers</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Klomp</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Hartemink</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>COUNTERPOINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? No.</article-title>
            <source>Chest</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>148</volume>
            <issue>6</issue>
            <fpage>1375</fpage>
            <page-range>1375-1379</page-range>
            <pub-id pub-id-type="pmid">26110487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieves Condoy</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Z&#x000fa;&#x000f1;iga V&#x000e1;zquez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>P&#x000e1;ez Hern&#x000e1;ndez</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez Herevia</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Acu&#x000f1;a Pinzon</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Superior Vena Cava Syndrome Due to Thymic Carcinoma.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Nov</month>
            <day>24</day>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>e11670</fpage>
            <pub-id pub-id-type="pmid">33391908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Rudnicki</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hiatt</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Mireles-Cabodevila</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A rapidly progressing Pancoast syndrome due to pulmonary mucormycosis: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2011</year>
            <month>Aug</month>
            <day>17</day>
            <volume>5</volume>
            <fpage>388</fpage>
            <pub-id pub-id-type="pmid">21849070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aokage</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuboi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zenke</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Horinouchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ishikura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kumagai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kanato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wakabayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukutani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>SI</given-names>
              </name>
              <collab>Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group</collab>
            </person-group>
            <article-title>Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer.</article-title>
            <source>Jpn J Clin Oncol</source>
            <year>2022</year>
            <month>Apr</month>
            <day>06</day>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>383</fpage>
            <page-range>383-387</page-range>
            <pub-id pub-id-type="pmid">34999817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McFadden</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Wiggins</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Contemporary Aggressive Surgical Resection for Superior Sulcus and Pancoast Lung Tumors.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <year>2017</year>
            <season>Spring</season>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-90</page-range>
            <pub-id pub-id-type="pmid">28684005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waseda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klikovits</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hoda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hoetzenecker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bertoglio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dieckmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Z&#x000f6;chbauer-M&#x000fc;ller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pirker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Prosch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>D&#x000f6;me</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klepetko</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.</article-title>
            <source>J Surg Oncol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>116</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-235</page-range>
            <pub-id pub-id-type="pmid">28407246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glassman</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Hyman</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pancoast tumor: a modern perspective on an old problem.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>340</fpage>
            <page-range>340-3</page-range>
            <pub-id pub-id-type="pmid">23702478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26553.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buderi</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Shackcloth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woolley</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Does induction chemoradiotherapy increase survival in patients with Pancoast tumour?</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>821</fpage>
            <page-range>821-825</page-range>
            <pub-id pub-id-type="pmid">27365009</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
